跳至主要内容
临床试验/NCT02936804
NCT02936804Unknown不适用

Key Technology in Precision Diagnosis and Therapy for Early Stage Lung Cancer: a Single Arm Clinical Trial

Shanghai Chest Hospital1 个研究点 分布在 1 个国家目标入组 60,000 人开始时间: 2016年12月最近更新:
适应症

试验速览

阶段
不适用
入组人数
60,000
试验地点
1
主要终点
Lung cancer incidence rate

研究概览

简要总结

The present study is a single arm clinical trial aiming to improve the key technology in the diagnosis and treatment of early stage lung cancer. 60,000 high-risk subjects (age 45-70) are planned to recruit and assign to the Low Dose Computed Tomography (LDCT) screening arm (Baseline + 2 rounds of biennial repeated LDCT screening). Management of positive screening test will be carried out by a pre-specified protocol.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
45 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Eligible participants were those aged 45-70 years, and with either of the following risk factors:
  • history of cigarette smoking ≥ 20 pack-years, and, if former smokers, had quit within the previous 15 years;
  • malignant tumors history in immediate family members;
  • personal cancer history;
  • professional exposure to carcinogens;
  • long term exposure to second-hand smoke;
  • long term exposure to cooking oil fumes.

排除标准

  • Had a CT scan of chest within last 12 months
  • History of any cancer within 5 years

结局指标

主要结局

Lung cancer incidence rate

时间窗: 5 years

Assess the number of lung cancer incidences after each round of screening. Compared the stage differences between screening arm and natural incidence.

次要结局

  • Lung cancer disease free survival(5 years)
  • Lung cancer mortality(5 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Baohui Han

: Vice-President

Shanghai Chest Hospital

研究点 (1)

Loading locations...

相似试验